Decreased Phenobarbital Absorption with Charcoal Administration for Chronic Renal Failure

Annals of Pharmacotherapy

Volumn 38, Issue 1, 2004, Pages 73-76

  Tanaka, Chie ^a,b   Yagi, Hidefumi ^a   Sakamoto, Michio ^a   Koyama, Yasuhiro ^c   Ohmura, Tadahiro ^c   Ohtani, Hisakazu ^b   Sawada, Yasufumi ^d  

^a Tomogikukai Showa Hospital   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Activated charcoal; Phenobarbital

Indexed keywords

ACTIVATED CARBON; ALGINIC ACID; AMIKACIN; BICARBONATE; CEFOPERAZONE; CHARCOAL; FUROSEMIDE; GLYCEROL; GLYCYRRHIZIC ACID; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; PIPERACILLIN; RANITIDINE; SPIRONOLACTONE; SUCRALFATE; SULBACTAM; TEPRENONE; URSODEOXYCHOLIC ACID;

AGED; ANEURYSM CLIP; ARTICLE; BIOAVAILABILITY; BLOOD; BRAIN ARTERY ANEURYSM; BRAIN HEMATOMA; BRAIN SURGERY; CASE REPORT; CHOLELITHIASIS; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONVULSION; DRUG ABSORPTION; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG COMBINATION; DRUG INTERACTION; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; INTESTINE ABSORPTION; LUNG CONGESTION; METABOLISM; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH ULCER; SUBARACHNOID HEMORRHAGE;

EID: 0346362454     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D241     Document Type: Article

References (14)

1. Yatzidis H, Oreopoulos D. Early clinical trial with sorbents. Kidney Int 1976;10(suppl 7):215-7.
2. Nakano N, Funada S, Honda Y, Nakano M. Selective adsorption by activated charcoal preparations for adsorbates of medical interest ranging in molecular weight from about 100 to 800. Chem Pharm Bull 1985;33:2084-90.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981:30:239-45.
4. Wilensky AJ, Friel PN, Levy RH, Comfort CP, Kaluzny SP. Kinetics of phenobarbital in normal subjects and epileptic patients. Eur J Clin Pharmacol 1982;23:87-92.
5. Mantyla R, Mannisto P, Nykanen S, Koponen A, Lamminsivu U. Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers. Eur J Clin Pharmacol 1983;24:227-30.
6. Amitai Y, Degami Y. Treatment of phenobarbital poisoning with multiple dose activated charcoal in an infant. J Emerg Med 1990;8:449-50.
7. American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Single-dose activated charcoal. J Toxicol Clin Toxicol 1997;35:721-41.
8. American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 1999;37:731-51.
9. Jones J, McMullen MJ, Dougherty J, Cannon L. Repetitive doses of activated charcoal in the treatment of poisoning. Am J Emerg Med 1987;5:305-11.
10. Honda Y, Nakano M, Nakano N. Prevention of gastrointestinal absorption of phenobarbital by activated carbon beads as oral adsorbent. J Pharmacobiodyn 1990;13:597-601.
11. Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol 1980;17:51-7.
12. Miyamoto M, Suyama T, Haji H. Examination of utility kremezin as an antidote for acute drug poisoning. Jpn J Hosp Pharm 1995;21:483-7.
13. Yukawa E, Higuchi S, Aoyama T. Influence of age and co-medication on steady-state phenobarbital serum level-dose ratios in Japanese paediatric patients. J Clin Pharm Ther 1992;17:249-53.
14. Frenia ML, Schauben JL, Wears RL, Janet LK, Chery AT, Thomas AK. Multiple-dose activated charcoal compared to urinary alkalinization for the enhancement of phenobarbital elimination. Clin Toxicol 1996:34:169-75.